Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Thoracic 1Other solid neoplasm 1Myeloid 1Dermatologic 1

Conditions

Primary Myelofibrosis 28Myeloproliferative Disorders 21Polycythemia Vera 16Thrombocythemia, Essential 7Neoplasms 7Pancreatic Neoplasms 6Multiple Myeloma 6Leukemia 6Hematologic Diseases 5Myelodysplastic Syndromes 4Graft vs Host Disease 4Colorectal Neoplasms 4Bone Marrow Diseases 4Thrombocytosis 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Bronchiolitis Obliterans Syndrome 3Breast Neoplasms 3Prostatic Neoplasms 2Lymphoma 2Uveal Melanoma 1Thalassemia 1Recurrence 1Preleukemia 1Precancerous Conditions 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1

Interventions

Rituximab 90Cyclophosphamide 30Lenalidomide 28Bendamustine Hydrochloride 24Prednisone 20Vincristine 19obinutuzumab 17Doxorubicin 16fludarabine 14ibrutinib 13tazemetostat 9idelalisib 9Deoxycholic Acid 9parsaclisib 8Prednisolone 8zanubrutinib 7venetoclax 7tofacitinib 7tisagenlecleucel 5pembrolizumab 5ofatumumab 5ibritumomab tiuxetan 5duvelisib 5Gemcitabine 5Bortezomib 5durvalumab 4aflibercept 4R-CHOP protocol 4Methylprednisolone 4Methotrexate 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Lymphoma, Follicular × ruxolitinib × Clear all
NCT04328844 2026-03-30

A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers

iOnctura

Phase 1 Active not recruiting
210 enrolled
DermatologicLymphoidMyeloidOther solid neoplasmThoracic

Uveal Melanoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Mesothelioma, Primary Myelofibrosis

NCT03774082 2025-12-11

REACH 5

Novartis

Phase 2 Completed
46 enrolled 21 charts
Lymphoid

Bronchiolitis Obliterans Syndrome, Graft vs Host Disease, Lymphoma, Follicular

NCT04934670 2024-08-27

2002

Xenikos

Phase 3 Terminated
12 enrolled 12 charts
Lymphoid

Pathologic Complete Response, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡